1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oral asciminib (ABL001) vs bosutinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who received ≥ 2 prior tyrosine kinase inhibitors (TKIs): A multicenter, open-label, randomized, phase 3 study
    Meeting Abstract

    Mauro, M.; Boquimpani, C.; Minami, Y.; Réa, D.; Kemp, C.; Hsu Schmitz, S. F.; Gopalakrishna, P.; Hochhaus, A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Bosutinib (BOS) vs imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE trial
    Meeting Abstract

    Cortes, J.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M.; Chuah, C.; Kim, D. W.; Reilly, L.; Jeynes-Ellis, A.; Leip, E.; Bardy-Bouxin, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Therapeutic TCR mimic monoclonal antibodies to intracellular oncogenic proteins
    Meeting Abstract

    Scheinberg, D. A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Trial in progress: A Phase I/II study of lintuzumab-Ac225 in older patients with untreated acute myeloid leukemia
    Meeting Abstract

    Jurcic, J. G.; Levy, M.; Park, J.; Ravandi, F.; Perl, A.; Pagel, J.; Smith, B. D.; Orozco, J.; Estey, E.; Kantarjian, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Next generation chimeric antigen receptor (CAR) T cells
    Meeting Abstract

    Brentjens, R.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Using epidemiologic evidence to guide recommendations for colorectal cancer screening in adults with cystic fibrosis
    Meeting Abstract

    Zauber, A. G.; Gini, A.; Khoruts, A.; Hadjiliadis, D.; Lowenfels, A.; Hempstead, S. E.; Fink, A.; Chen, J. C.; Meester, R.; Maisonneuve, P.; more...
    Annals of Epidemiology (2017)

    Fulltext@MSK | Save
  • CML management in 2017
    Meeting Abstract

    Mauro, M. J.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Molecular determinants of response in AML
    Meeting Abstract

    Levine, R. L.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • En bloc resection versus intralesional surgery in the treatment of giant cell tumor of the spine
    Journal Article

    Charest-Morin, R.; Fisher, C. G.; Varga, P. P.; Gokaslan, Z. L.; Rhines, L. D.; Reynolds, J. J.; Dekutoski, M. B.; Quraishi, N. A.; Bilsky, M. H.; Fehlings, M. G.; more...
    Spine (2017)

    Fulltext@MSK | Save
  • Effects of roniciclib in preclinical models of anaplastic thyroid cancer
    Journal Article

    Lin, S. F.; Lin, J. D.; Hsueh, C.; Chou, T. C.; Wong, R. J.
    Oncotarget (2017)

    Fulltext@MSK | Save